Form EFFECT Checkpoint Therapeutics,

Go back to Form EFFECT Checkpoint Therapeutics,

Fortress Biotech (FBIO) PT Raised to $24 at H.C. Wainwright

April 9, 2024 6:07 AM EDT

H.C. Wainwright analyst Joseph Pantginis raised the price target on Fortress Biotech (NASDAQ: FBIO) to $24.00 (from $10.00) while maintaining a Buy rating.

The analyst comments "We are taking this opportunity to: (1) highlight significant upcoming regulatory milestones for Fortress partners, and; (2) bring attention to a significant... More